John R. Moore, General Counsel at Edgewise Therapeutics, Inc. (EWTX), sold 1,930 shares at $16.45 ($32K) on 2025-05-02, disclosed to the SEC on 2025-05-07.
Seasonal sale ($32k) by General Counsel — this insider has traded EWTX in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| EWTX | SELL | 2024-09-24 | $2.6M | — | Filing → |
| EWTX | SELL | 2024-05-03 | $37K | — | Filing → |
| EWTX | SELL | 2024-02-09 | $834K | — | Filing → |